Boston, MA -- In March of 2020, Mass General Brigham implemented a new policy: everyone working at the hospitals would be required to wear a surgical mask. At the time, the concept of universal masking was new and its potential effectiveness unclear. But now, a new study led by investigators from Brigham and Women's Hospital and published in JAMA makes it clear: after universal masking was implemented at Mass General Brigham, the rate of COVID-19 infection among health care workers dropped significantly.
"These results support universal masking as part of a multipronged, infection-reduction strategy in health care settings," said corresponding author Deepak L. Bhatt, MD, MPH, FACC, executive director of Interventional Cardiovascular Programs at the Brigham. "While we studied health care workers, the results also apply to other situations in which social distancing is not possible. For those who have been waiting for data before adopting the practice, this paper makes it clear: Masks work."
The study assessed infection rates for SARS-CoV-2, the virus that causes COVID-19, among Mass General Brigham health care workers before and after a universal masking policy was put in place system-wide. Mass General Brigham includes 12 hospitals, including Brigham and Women's Hospital and Massachusetts General Hospital, and 78,000 employees in Massachusetts. Using electronic medical records, Bhatt and colleagues examined data from March 1 to April 30, looking at test results for health care workers who had symptoms of COVID-19 (throughout the study period, anyone with symptoms of COVID-19 could be tested for infection). Of 9,850 health care workers tested over the study period, 1,271 (13 percent) had positive results for SARS-CoV-2.
The team compared rates during the pre-intervention period of March 1 to March 24 to the intervention period of April 11 to April 30 (the team allowed for a transition period from March 25 to April 11 to account for a lag in symptoms). Before the masking policy was implemented, the SARS-CoV-2 positivity rate increased exponentially from 0 percent to 21 percent, with cases doubling every 3.6 days. After the policy was implemented, the positivity rate decreased linearly from 15 percent to 11 percent. Case numbers continued to increase in Massachusetts throughout the study period.
In their paper, the authors outline other interventions in Massachusetts and at Mass General Brigham during the study period that may have confounded their results. They also note that during a pandemic it is likely not feasible to conduct a randomized trial to test whether universal masking alone accounts for the dramatic reversal in the SARS-CoV-2 positive rate.
"This is the most direct COVID-19 research data to this point that is based on testing of health care workers pre- and post-implementation of universal masking policies," said Dean Hashimoto, MD, the chief medical officer for Occupational Health Services at Mass General Brigham. "When our Infection Control leaders announced a universal masking policy early in the pandemic it was a bold move, especially at a time when, like all health systems, we were facing PPE shortages. But the results of this study demonstrate that requiring masks for all hospital staff regardless of role in the organization was critical to protecting our employees."
Conflict of interest disclosures can be found in the paper.
Paper cited: Wang X et al. "Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers" JAMA DOI:10.1001/jama.2020.12897
Brigham Health, a global leader in creating a healthier world, consists of Brigham and Women's Hospital, Brigham and Women's Faulkner Hospital, the Brigham and Women's Physicians Organization and many related facilities and programs. With more than 1,000 inpatient beds, approximately 60,000 inpatient stays and 1.7 million outpatient encounters annually, Brigham Health's 1,200 physicians provide expert care in virtually every medical and surgical specialty to patients locally, regionally and around the world. An international leader in basic, clinical and translational research, Brigham Health has nearly 5,000 scientists, including physician-investigators, renowned biomedical researchers and faculty supported by over $700 million in funding. The Brigham's medical preeminence dates back to 1832, and now, with 19,000 employees, that rich history is the foundation for its commitment to research, innovation, and community. Boston-based Brigham and Women's Hospital is a teaching affiliate of Harvard Medical School and dedicated to educating and training the next generation of health care professionals. For more information, resources, and to follow us on social media, please visit brighamandwomens.org.